Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector

This paper demonstrates that radical regulatory changes can be tantamount to technological revolutions by studying Indian pharmaceutical firms. It shows that radical regulatory changes such as the Indian Patent Act of 1970, the New Industrial Policy of 1991 and the signing of TRIPS (Trade Related Intellectual Property Rights System) in 1995 served to open up new economic opportunities and constraints in the wake of which the winners and losers were selected as a function of the dynamic firm capabilities most appropriate for the new market environment.

MoreLess

Year of publication:	2008
Authors:	Athreye, Suma ; Kale, Dinar ; Ramani, Shyama V.
Institutions:	United Nations University-Maastricht Economic Research Institute of Innovation and Technology (UNU-MERIT)
Subject:	International Marketing \| R&D Management \| India \| Pharmaceutical Sector \| Corporate Strategy

More details

Extent:	application/pdf
Series:	MERIT Working Papers.
Type of publication:	Book / Working Paper
Notes:	The text is part of a series UNU-MERIT Working Papers Number 041
Classification:	L11 - Production, Pricing, and Market Structure Size; Size Distribution of Firms ; L22 - Firm Organization and Market Structure: Markets vs. Hierarchies; Vertical Integration ; L51 - Economics of Regulation ; L65 - Chemicals; Rubber; Drugs; Biotechnology ; M31 - Marketing ; O32 - Management of Technological Innovation and R&D ; O34 - Intellectual Property Rights: National and International Issues ; O53 - Asia including Middle East
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10010712160